First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia

CAR T cells have shown clinical efficacy for acute lymphoblastic leukemia, but this therapy has not been effective for acute myeloid leukemia (AML), and other treatment options are needed. Theoretically, CAR-NK cells have a more favorable toxicity profile compared to CAR T cells, especially in avoid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Cancer Res
Main Authors: Tang, Xiaowen, Yang, Lin, Li, Zheng, Nalin, Ansel P, Dai, Haiping, Xu, Ting, Yin, Jia, You, Fengtao, Zhu, Mingqing, Shen, Wenhong, Chen, Guanghua, Zhu, Xiaming, Wu, Depei, Yu, Jianhua
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6048396/
https://ncbi.nlm.nih.gov/pubmed/30034945
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados